-- Robert Preidt
TUESDAY, Nov. 27 (HealthDay News) -- People with an overactive
thyroid (hyperthyroidism) are at increased risk for a common and
potentially dangerous heart rhythm disorder called atrial
fibrillation, a large study suggests.
The researchers said their findings point to the value of
long-term screening for atrial fibrillation in people with
hyperthyroidism, which causes many of the body's functions to speed
About one in 100 women and one in 1,000 men develop
hyperthyroidism at some point in their lives and the condition can
occur at any age.
The study, led by Christian Selmer of Gentofte University
Hospital, in Hellerup, Denmark, included more than 586,000 Danes
who had undergone a thyroid function blood test between 2000 and
2010. During an average 5.5 years of follow-up, 3 percent of the
patients were diagnosed with atrial fibrillation and 53 percent of
those patients were women.
However, compared to patients with normal thyroid function,
those with subclinical (early stage) hyperthyroidism had a 30
percent increased risk of atrial fibrillation, while those with
high-normal thyroid function had a 12 percent increased risk.
People with an underactive thyroid (hypothyroidism) had a lower
risk of atrial fibrillation than those with normal thyroid
While this study found a close association between thyroid
activity and atrial fibrillation, it does not prove a direct
cause-and-effect link, the researchers wrote. They added that their
findings "support long-term screening for atrial fibrillation in
patients with thyroid disease."
Two experts in the United States said the study raises new
questions for doctors and patients.
"While it is now well-known fact that patients with hyperthyroidism have increased risk of atrial fibrillation, this study extends that finding to patients with subclinical hyperthyroidism," said Dr. Sripal Bangalore, an assistant professor in the department of medicine at NYU Langone Medical Center, in New York City. "However, given that it is an observational study, it is difficult to attribute causal association even though there is strong biological plausibility for such association."
Still, Dr. Suzanne Steinbaum, a preventive cardiologist at Lenox
Hill Hospital, in New York City, agreed with the authors that
"investigating for subclinical hyperthyroidism is essential to
adequately assess the risk for atrial fibrillation [in patients]
and to treat it before it becomes a cardiac issue."
Bangalore believes that many more questions remain unanswered,
"Further studies are needed," he said, "to evaluate the next step: What should be done for patients with subclinical hyperthyroidism to reduce the risk of atrial fibrillation, and whether treatment of subclinical hyperthyroidism would reduce this increased risk of atrial fibrillation? Up until that time, close follow-up of patients with subclinical hyperthyroidism for atrial fibrillation is warranted."
The study was published online Nov. 27 in
The U.S. National Institute of Diabetes and Digestive and Kidney
Diseases has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.